557 related articles for article (PubMed ID: 3552334)
1. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
[TBL] [Abstract][Full Text] [Related]
2. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
3. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
[TBL] [Abstract][Full Text] [Related]
4. Restoration of cell-mediated immune responses with transfer factor.
Kirkpatrick CH
Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
[TBL] [Abstract][Full Text] [Related]
5. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
Elliott ST; Hanifin JM
Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
[TBL] [Abstract][Full Text] [Related]
6. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens.
Lesourd BM; Winters WD; Kniker WT
J Clin Lab Immunol; 1986 Apr; 19(4):187-92. PubMed ID: 3723589
[TBL] [Abstract][Full Text] [Related]
7. Antigen specific stimulation of immune responses during long-term repeated skin testing with multiple antigens.
Lesourd BM; Winters WD; Darnell B
J Clin Lab Immunol; 1986 Sep; 21(1):17-22. PubMed ID: 2433448
[TBL] [Abstract][Full Text] [Related]
8. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
Rocklin RE
Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities in cell-mediated immune functions to Haemophilus influenzae chronic purulent infections of the upper respiratory tract.
Drexhage HA; van de Plassche EM; Kokjé M; Leezenberg HA
Clin Immunol Immunopathol; 1983 Aug; 28(2):218-28. PubMed ID: 6603318
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
Kondo H; Rabin BS; Rodnan GP
J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
[TBL] [Abstract][Full Text] [Related]
12. Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.
van de Plassche-Boers EM; Tas M; de Haan-Meulman M; Kleingeld M; Drexhage HA
Clin Exp Immunol; 1988 Sep; 73(3):348-54. PubMed ID: 3264768
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and T-cell-mediated immunity to proteins of the mouse mammary tumour virus (MMTV).
de Ricqlès D; Olomucki A; Gosselin F; Lidereau R
Eur Cytokine Netw; 1993; 4(2):153-60. PubMed ID: 8391340
[TBL] [Abstract][Full Text] [Related]
14. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes.
Rocklin RE; Chess L; MacDermott RP; Schlossman SF; David JR
Rheumatology; 1975; 6():98-105. PubMed ID: 1105751
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
[TBL] [Abstract][Full Text] [Related]
16. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
[TBL] [Abstract][Full Text] [Related]
18. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
19. Blocking plasma factors of migration inhibition factor production in patients with cervical carcinoma. A possible role in vivo.
Favila L; Jiménez L; Casto ME; García-García G; Gutiérrez A; Pulido I
J Natl Cancer Inst; 1978 Jun; 60(6):1279-82. PubMed ID: 349168
[TBL] [Abstract][Full Text] [Related]
20. Production of migration inhibitory factor in response to bacterial and fungal antigens in patients with untreated Graves' disease.
Wall JR; Ryan EA
Can Med Assoc J; 1980 Jun; 122(11):1264-9. PubMed ID: 6446374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
